Clock Genes Regulate Ca 2+ Signaling and Mitochondrial Bioenergetics to Inhibit Sjögren Disease
Arthritis & Rheumatology · 11.05.2026
DOI: 10.1002/art.70183 ↗Kurz gefasst
Fachartikel in der Zeitschrift Arthritis & Rheumatology, online erschienen am 11.05.2026. Verfasst von Viktor R Drel und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Periodontics, University of Texas Health San Antonio. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 63 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIDCR NIH HHS, Department of Biotechnology welcome trust, National Institute of Dental and Craniofacial Research.
Abstract (Originalsprache)
Objective
Although Ca 2 + signaling and metabolism have been identified as key determinants for the development of Sjögren disease (SjD), the intricate connection between them and salivary gland physiology remains poorly understood.
Methods
Fluorescence‐based Ca 2+ imaging, RNA sequencing, and mitochondrial activity were used to investigate the effects of circadian rhythm and salivary gland dysfunction. Critical findings were confirmed by studying mouse models of SjD and human salivary gland samples.
Results
We identified that Ca 2+ entry is essential in modulating Clock genes and circadian rhythm, which also modulate salivary gland secretion and the expression of Stim and Orai genes. Mechanistically, our data show that Bmal2 binding in the promoter region of Stim1 modulates its expression, thereby regulating Ca 2+ entry and mitochondrial bioenergetics and providing cyclic rhythm–mediated regulation of cellular physiology. To assess Ca 2+ ‐dependent circadian rhythms, we used diet perturbation, in which a Ca 2+ ‐deficient diet specifically impacts the Clock gene's rhythm, which was reversed by Ca 2+ supplementation. Circadian rhythm–mediated regulation of fluid secretion, as well as STIM1 genes, was also altered in an SjD mouse model. In addition, human patients with SjD also showed dysregulation of CLOCK and STIM1 genes, which could alter salivary physiology, leading to the development of the SjD phenotype.
Conclusion
Our results provide the first comprehensive evidence of a reciprocal relationship between circadian rhythm, Ca 2+ signaling, and metabolism, which is critical for cellular physiology and disease development/progression. image
Autor:innen und Institutionen
- Department of Periodontics, University of Texas Health San Antonio.
- Center for Mitochondrial Medicine, Department of Medicine, University of Texas Health San Antonio.
- Department of Developmental Dentistry, University of Texas Health San Antonio.
- Department of Biological Sciences and Center for Human and the Environment, North Carolina State University, Raleigh.
- Laboratory of Calciomics and Systemic Pathophysiology, Regional Centre for Biotechnology, Faridabad, India.
ORCID-Profile: Rajender K Motiani, Brij B Singh
Förderung
- NIDCR NIH HHS
- Department of Biotechnology welcome trust
- National Institute of Dental and Craniofacial Research
Zitieren
APA
Drel, V. R., Venkatesan, M., Jasrotia, R. S., Sun, Y., Nascimento da Conceicao, V., Vishnu, N., Varadarajan, S. N., Bovilla, V. R., Motiani, R. K., Gaddameedhi, S., Mishra, B. B., Madesh, M., & Singh, B. B. (2026). Clock Genes Regulate Ca 2+ Signaling and Mitochondrial Bioenergetics to Inhibit Sjögren Disease. Arthritis & Rheumatology. https://doi.org/10.1002/art.70183
Vancouver
Drel VR, Venkatesan M, Jasrotia RS, Sun Y, Nascimento da Conceicao V, Vishnu N, et al. Clock Genes Regulate Ca 2+ Signaling and Mitochondrial Bioenergetics to Inhibit Sjögren Disease. Arthritis & Rheumatology. 2026. doi:10.1002/art.70183
BibTeX
@article{Drel2026,
author = {Drel, Viktor R and Venkatesan, Manigandan and Jasrotia, Rahul S and Sun, Yuyang and Nascimento da Conceicao, Viviane and Vishnu, Neelanjan and Varadarajan, Shankara N and Bovilla, Venugopal R and Motiani, Rajender K and Gaddameedhi, Shobhan and Mishra, Bibhuti B and Madesh, Muniswamy and Singh, Brij B},
title = {Clock Genes Regulate Ca 2+ Signaling and Mitochondrial Bioenergetics to Inhibit Sjögren Disease},
journal = {Arthritis & Rheumatology},
year = {2026},
doi = {10.1002/art.70183}
}
EUVIMED